Target intelligence / Profile preview

BOK antisense RNA 1 (BOK-AS1)

Target
BOK-AS1
Molecular classification
Long non-coding RNA, Natural antisense transcript, Other
01

Overview

BOK antisense RNA 1 (BOK-AS1) is a long non-coding RNA transcribed from the Bok gene locus in an antisense orientation and acts as a regulatory molecule primarily involved in modulating apoptosis and influencing cellular responses to stress[1][3]. BOK-AS1 has been shown to be upregulated in certain cancers, such as esophageal squamous cell carcinoma, especially after radiotherapy, where it promotes the expression of the oncofetal gene WISP1 and contributes to radioresistance by mitigating irradiation-induced DNA damage and activating the PI3K pathway[1]. BOK-AS1 acts as a natural antisense transcript of the proapoptotic Bok gene, serving as a negative regulator of Bok-mediated apoptotic signaling; it is expressed in testis and certain cancer tissues[1]. While BOK-AS1 itself does not induce apoptosis, it can inhibit Bok-induced apoptosis in vitro, suggesting a context-dependent regulatory function in cell survival and response to genotoxic stress[1]. There is no evidence that BOK-AS1 is currently a direct therapeutic target or that any drugs are known to interact with it[1][3].

Other names
BOK-ASNCRNA00151BOKASNAToBnon-protein coding RNA 151LOC105373974
02

Biological functions

Regulation of apoptosisModulation of cellular response to stressModulation of radiotherapy responseNegative regulator of Bok-induced apoptosisOther
03

Disease associations

CancerRadioresistanceTumorigenesisOther

Beyond the preview

Go deeper on BOK antisense RNA 1 (BOK-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BOK antisense RNA 1 (BOK-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call